Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants

MLA

Holt, Anders, et al. “Gastrointestinal Bleeding Risk Following Concomitant Treatment with Oral Glucocorticoids in Patients on Non-Vitamin K Oral Anticoagulants.” Heart, vol. 108, no. 8, Jan. 2022, pp. 626–32. EBSCOhost, https://doi.org/10.1136/heartjnl-2021-319503.

APA

Holt, A., Blanche, P., Zareini, B., Rasmussen, P. V., Strange, J. E., Rajan, D., Jensen, M. H., El-Sheikh, M., Schjerning, A.-M., Schou, M., Gislason, G., Torp-Pedersen, C., McGettigan, P., & Lamberts, M. (2022). Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants. Heart, 108(8), 626–632. https://doi.org/10.1136/heartjnl-2021-319503

Chicago

Holt, Anders, Paul Blanche, Bochra Zareini, Peter Vibe Rasmussen, Jarl Emanuel Strange, Deepthi Rajan, Mads Hashiba Jensen, et al. 2022. “Gastrointestinal Bleeding Risk Following Concomitant Treatment with Oral Glucocorticoids in Patients on Non-Vitamin K Oral Anticoagulants.” Heart 108 (8): 626–32. doi:10.1136/heartjnl-2021-319503.